Carmell Therapeutics Corp - US shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Carmell Therapeutics Corp - US
Tip: Access up to 7 years of quarterly data
All positions including Carmell Therapeutics Corp - US held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Carmell Therapeutics Corp - US by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $452 | 119 | 3.81 |
2023-09-30 | $310 | 86 | 3.60 |
Top funds holding Carmell Therapeutics Corp - US
View all funds holding Carmell Therapeutics Corp - US